Skip to main content

Advertisement

SpringerLink
Log in

Multiparametric cardiac magnetic resonance unveiling the mechanisms and early manifestations of anticancer drug cardiotoxicity

  • Commentary
  • Published:
European Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

CMR:

Cardiac magnetic resonance

CTRCD:

Cancer therapy–related cardiac dysfunction

ECV:

Extracellular volume

GLS:

Global longitudinal strain

LGE:

Late gadolinium enhancement

LVEF:

Left ventricular ejection fraction

References

  1. International Agency for Research on Cancer. In: Cancer today Available via https://gco.iarc.fr/today/home. Accessed 22 Jun 2023

  2. Porter C, Azam TU, Mohananey D et al (2022) Permissive cardiotoxicity: the clinical crucible of cardio-oncology. JACC CardioOncol 4:302–312. https://doi.org/10.1016/j.jaccao.2022.07.005

  3. Esposito A, Gallone G, Palmisano A et al (2020) The current landscape of imaging recommendations in cardiovascular clinical guidelines: toward an imaging-guided precision medicine. Radiol Med 125:1013–1023. https://doi.org/10.1007/s11547-020-01286-9

  4. Čelutkienė J, Pudil R, López-Fernández T et al (2020) Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the Eur. Eur J Heart Fail 22:1504–1524. https://doi.org/10.1002/ejhf.1957

    Article  CAS  PubMed  Google Scholar 

  5. Bellenger NG, Burgess MI, Ray SG et al (2000) Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are they interchangeable? Eur Heart J 21:1387–1396. https://doi.org/10.1053/euhj.2000.2011

    Article  CAS  PubMed  Google Scholar 

  6. Ong G, Brezden-Masley C, Dhir V et al (2018) Myocardial strain imaging by cardiac magnetic resonance for detection of subclinical myocardial dysfunction in breast cancer patients receiving trastuzumab and chemotherapy. Int J Cardiol 261:228–233. https://doi.org/10.1016/j.ijcard.2018.03.041

    Article  PubMed  Google Scholar 

  7. Farhad H, Staziaki PV, Addison D et al (2016) Characterization of the changes in cardiac structure and function in mice treated with anthracyclines using serial cardiac magnetic resonance imaging. Circ Cardiovasc Imaging 9:1–8. https://doi.org/10.1161/CIRCIMAGING.115.003584

    Article  Google Scholar 

  8. Saunderson CED, Plein S, Manisty CH (2021) Role of cardiovascular magnetic resonance imaging in cardio-oncology. Eur Heart J Cardiovasc Imaging 22:383–396. https://doi.org/10.1093/ehjci/jeaa345

    Article  PubMed  Google Scholar 

  9. Thavendiranathan P, Shalmon T, Fan CS et al (2023) Comprehensive cardiovascular magnetic resonance tissue characterization and cardiotoxicity in women with breast cancer. JAMA Cardiol 8:524–534. https://doi.org/10.1001/jamacardio.2023.0494

  10. Neilan TG, Coelho-Filho OR, Pena-Herrera D et al (2012) Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines. Am J Cardiol 110:1679–1686. https://doi.org/10.1016/j.amjcard.2012.07.040

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

  1. IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089, Milan, Italy

    Marco Francone, Stefano Figliozzi, Lorenzo Monti & Federica Catapano

  2. Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy

    Marco Francone, Lorenzo Monti & Federica Catapano

  3. Division of Cardiovascular and Interventional Radiology, Dep. for Bioimaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria

    Christian Loewe

Authors
  1. Marco Francone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefano Figliozzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lorenzo Monti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christian Loewe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Federica Catapano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marco Francone.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Marco Francone.

Conflict of interest

Marco Francone is a member of the European Radiology Scientific Editorial Board and has therefore not taken parti in review or selection process of this article. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was not required.

Ethical approval

Institutional Review Board approval was not required.

Study subjects or cohorts overlap

Not applicable.

Methodology

• Invited commentary

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Francone, M., Figliozzi, S., Monti, L. et al. Multiparametric cardiac magnetic resonance unveiling the mechanisms and early manifestations of anticancer drug cardiotoxicity. Eur Radiol 33, 8439–8441 (2023). https://doi.org/10.1007/s00330-023-09948-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-023-09948-8

Search

Navigation